JP2008528532A - 統合失調症のアドオン治療用spm927 - Google Patents
統合失調症のアドオン治療用spm927 Download PDFInfo
- Publication number
- JP2008528532A JP2008528532A JP2007552583A JP2007552583A JP2008528532A JP 2008528532 A JP2008528532 A JP 2008528532A JP 2007552583 A JP2007552583 A JP 2007552583A JP 2007552583 A JP2007552583 A JP 2007552583A JP 2008528532 A JP2008528532 A JP 2008528532A
- Authority
- JP
- Japan
- Prior art keywords
- use according
- unsubstituted
- day
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64741005P | 2005-01-28 | 2005-01-28 | |
EP05001843A EP1688137A1 (en) | 2005-01-28 | 2005-01-28 | SPM 927 for add-on therapy of schizophrenia |
PCT/EP2006/000722 WO2006079547A2 (en) | 2005-01-28 | 2006-01-27 | Spm 927 for add-on therapy of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2008528532A true JP2008528532A (ja) | 2008-07-31 |
Family
ID=36636204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007552583A Withdrawn JP2008528532A (ja) | 2005-01-28 | 2006-01-27 | 統合失調症のアドオン治療用spm927 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1841417A2 (ko) |
JP (1) | JP2008528532A (ko) |
KR (1) | KR20070096058A (ko) |
AR (1) | AR057643A1 (ko) |
AU (1) | AU2006208630B2 (ko) |
BR (1) | BRPI0607043A2 (ko) |
CA (1) | CA2595330A1 (ko) |
EA (1) | EA015566B1 (ko) |
IL (1) | IL183973A0 (ko) |
MX (1) | MX2007009070A (ko) |
NO (1) | NO20074361L (ko) |
WO (1) | WO2006079547A2 (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2651679C (en) * | 2006-06-15 | 2017-01-03 | Schwarz Pharma Ag | Pharmaceutical composition with synergistic anticonvulsant effect |
EP1873527A1 (en) | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
EP1920780A1 (en) * | 2006-10-12 | 2008-05-14 | Schwarz Pharma Ag | Peptide compounds for the treatment of hyperexcitability disorders |
CN101466390B (zh) * | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
EP2214657A1 (en) | 2007-10-23 | 2010-08-11 | UCB Pharma GmbH | Compounds for treating demyelination conditions |
WO2010077916A1 (en) * | 2008-12-16 | 2010-07-08 | Eurand, Inc. | Compositions comprising melperone |
EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
US20130251813A1 (en) | 2010-12-02 | 2013-09-26 | Ucb Pharma Gmbh | Formulation of lacosamide |
CN115813888A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
AU2017384392B2 (en) | 2016-12-20 | 2023-05-25 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
BR112019027037B1 (pt) | 2017-06-26 | 2022-04-05 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico contendo asenapina e polímero híbrido acrílico de silicone, e processo para fabricar uma camada contendo asenapina para uso no referido sistema |
CA3088356A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
JP7268026B2 (ja) | 2017-12-05 | 2023-05-02 | サノビオン ファーマシューティカルズ インク | 非ラセミ混合物およびその使用 |
CN110958876B (zh) | 2018-06-20 | 2020-12-18 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
CN114401717A (zh) | 2019-06-04 | 2022-04-26 | 赛诺维信制药公司 | 修饰释放配制品及其用途 |
US11278634B1 (en) | 2021-02-12 | 2022-03-22 | Extrovis Ag | Stable parenteral composition of lacosamide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5773475A (en) * | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
DE60120104T2 (de) | 2001-03-20 | 2006-09-21 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz |
DE60100055T2 (de) | 2001-03-21 | 2003-07-24 | Schwarz Pharma Ag | Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen |
-
2006
- 2006-01-27 JP JP2007552583A patent/JP2008528532A/ja not_active Withdrawn
- 2006-01-27 AR ARP060100304A patent/AR057643A1/es not_active Application Discontinuation
- 2006-01-27 KR KR1020077019581A patent/KR20070096058A/ko not_active Application Discontinuation
- 2006-01-27 AU AU2006208630A patent/AU2006208630B2/en not_active Ceased
- 2006-01-27 MX MX2007009070A patent/MX2007009070A/es active IP Right Grant
- 2006-01-27 BR BRPI0607043-4A patent/BRPI0607043A2/pt not_active IP Right Cessation
- 2006-01-27 WO PCT/EP2006/000722 patent/WO2006079547A2/en active Application Filing
- 2006-01-27 EP EP06706448A patent/EP1841417A2/en not_active Withdrawn
- 2006-01-27 CA CA002595330A patent/CA2595330A1/en not_active Abandoned
- 2006-01-27 EA EA200701594A patent/EA015566B1/ru not_active IP Right Cessation
-
2007
- 2007-06-14 IL IL183973A patent/IL183973A0/en unknown
- 2007-08-27 NO NO20074361A patent/NO20074361L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20074361L (no) | 2007-10-26 |
WO2006079547A3 (en) | 2006-09-21 |
WO2006079547A2 (en) | 2006-08-03 |
EA200701594A1 (ru) | 2008-02-28 |
AR057643A1 (es) | 2007-12-12 |
KR20070096058A (ko) | 2007-10-01 |
EA015566B1 (ru) | 2011-10-31 |
MX2007009070A (es) | 2007-09-12 |
AU2006208630A1 (en) | 2006-08-03 |
IL183973A0 (en) | 2008-12-29 |
CA2595330A1 (en) | 2006-08-03 |
EP1841417A2 (en) | 2007-10-10 |
AU2006208630B2 (en) | 2011-09-29 |
BRPI0607043A2 (pt) | 2009-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008528532A (ja) | 統合失調症のアドオン治療用spm927 | |
US20060252749A1 (en) | Lacosamide for add-on therapy of psychosis | |
JP5038892B2 (ja) | 本態性振せん及び他の振せん症候群を治療するためのペプチド化合物の新しい使用 | |
JP6158376B2 (ja) | 相乗的抗痙攣効果を有する医薬組成物 | |
AU2007260208B2 (en) | Peptide compounds for treating refractory status epilepticus | |
AU2005232395B2 (en) | Use of peptidic compounds for the prophylaxis and treatment of chronic headache | |
JP4938656B2 (ja) | ジスキネジアの治療のためのペプチド化合物の新規の使用 | |
US20100324144A1 (en) | Therapy for hyperexcitability disorders | |
ZA200705892B (en) | SPM 927 for add-on therapy of schizophrenia | |
JP4213339B2 (ja) | 発作を治療するのに有用なアミノ酸誘導体 | |
RU2508106C2 (ru) | Способы и композиции для лечения шизофрении с использованием атипичной нейролептической комбинированной терапии | |
RU2508096C2 (ru) | Способы и композиции для лечения шизофрении с использованием нейролептической комбинированной терапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081209 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20100205 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100205 |